Vytrus Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	148	64	16	13	23	-
Market Cap Growth	589.85%	294.97%	29.02%	-46.26%	-	-
Enterprise Value	146	62	16	14	23	-
Last Close Price	19.75	8.55	2.16	1.86	3.40	-
PE Ratio	51.25	22.21	15.95	23.17	38.81	-
Forward PE	41.38	21.98	21.98	11.97	26.21	-
PS Ratio	15.32	6.64	2.67	2.69	5.24	-
PB Ratio	14.40	6.24	2.23	2.38	4.94	-
P/TBV Ratio	27.73	12.02	5.06	7.59	14.68	-
P/FCF Ratio	51.43	22.29	9.35	16.55	38.78	-
P/OCF Ratio	38.06	16.50	8.83	13.96	22.90	-
EV/Sales Ratio	15.09	6.45	2.64	2.91	5.20	-
EV/EBITDA Ratio	43.11	18.41	13.67	22.96	30.92	-
EV/EBIT Ratio	46.34	19.79	16.34	33.82	38.42	-
EV/FCF Ratio	50.67	21.64	9.24	17.93	38.49	-
Debt / Equity Ratio	0.12	0.12	0.24	0.39	0.21	0.22
Debt / EBITDA Ratio	0.37	0.37	1.51	3.49	1.31	0.94
Debt / FCF Ratio	0.43	0.43	1.02	2.72	1.63	4.09
Net Debt / Equity Ratio	-0.21	-0.21	-0.10	0.18	0.06	-0.08
Net Debt / EBITDA Ratio	-0.65	-0.65	-0.64	1.63	0.35	-0.36
Net Debt / FCF Ratio	-0.76	-0.76	-0.43	1.27	0.43	-1.56
Asset Turnover	0.75	0.75	0.60	0.54	0.59	0.53
Inventory Turnover	1.47	1.47	1.07	0.72	1.02	1.11
Quick Ratio	2.67	2.67	2.60	1.90	0.99	1.92
Current Ratio	3.03	3.03	3.03	2.46	1.33	2.26
Return on Equity (ROE)	32.91%	32.91%	16.23%	10.85%	13.44%	11.45%
Return on Assets (ROA)	15.29%	15.29%	6.02%	2.92%	4.99%	3.82%
Return on Invested Capital (ROIC)	36.07%	39.94%	15.39%	7.17%	13.62%	11.25%
Return on Capital Employed (ROCE)	24.50%	24.50%	10.00%	4.90%	9.00%	6.40%
Earnings Yield	1.95%	4.50%	6.27%	4.32%	2.58%	-
FCF Yield	1.94%	4.49%	10.70%	6.04%	2.58%	-
Buyback Yield / Dilution	0.10%	0.10%	-11.71%	-	-	-0.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.